To test this hypothesis, we analyzed effects of the ectopic expression of NPRL2 in the presence or absence of the DNA-damaging agent cisplatin on tumor cell growth and apoptosis in a panel of NSCLC cell lines with varied status of the endogenous NPRL2 gene and protein expression and cisplatin sensitivity. Here, NPRL2 is linked to non-small cell lung carcinoma.